13F HOLDINGS REPORT
Birchview Capital, LP
Quarter ended Q3 2023 · Filed August 8, 2023 · Accession 0001618205-23-000004
Total Value
$133.4M
Positions
54
Other Managers
0
Confidential Omitted
No
Holdings (54)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 728,585 | $46.6M | 34.92% |
| 2 | PROTHENA CORP PLC | PRTA | 156,111 | $10.7M | 7.99% |
| 3 | NEUROCRINE BIOSCIENCES INC | NBIX | 84,240 | $7.9M | 5.95% |
| 4 | BIODESIX INC | BDSX | 5,039,633 | $6.2M | 4.65% |
| 5 | ACADIA PHARMACEUTICALS INC | ACAD | 249,400 | $6.0M | 4.48% |
| 6 | QUIDELORTHO CORP | QDEL | 65,203 | $5.4M | 4.05% |
| 7 | AZIYO BIOLOGICS INC | ELUT | 1,655,184 | $3.9M | 2.93% |
| 8 | IMMUNOGEN INC | 45253H101 | 190,000 | $3.6M | 2.69% |
| 9 | UNITED THERAPEUTICS CORP | UTHR | 15,000 | $3.3M | 2.48% |
| 10 | OVINTIV INC | OVV | 84,200 | $3.2M | 2.40% |
| 11 | HARROW HEALTH INC | HROW | 150,000 | $2.9M | 2.14% |
| 12 | PHREESIA INC | PHR | 82,700 | $2.6M | 1.92% |
| 13 | MASIMO CORP | MASI | 15,280 | $2.5M | 1.88% |
| 14 | FOGHORN THERAPEUTICS INC | FHTX | 264,843 | $1.9M | 1.40% |
| 15 | INHIBRX INC | INBX | 70,448 | $1.8M | 1.37% |
| 16 | ACCELERATE DIAGNOSTICS INC | 00430H102 | 2,252,388 | $1.8M | 1.37% |
| 17 | ALKERMES PLC | ALKS | 50,000 | $1.6M | 1.17% |
| 18 | ALPHATEC HOLDINGS INC | ATEC | 80,000 | $1.4M | 1.08% |
| 19 | EQUITRANS MIDSTREAM CORPORATIO | 294600101 | 133,050 | $1.3M | 0.95% |
| 20 | CORCEPT THERAPEUTICS INC | CORT | 50,000 | $1.1M | 0.83% |
| 21 | APELLIS PHARMACEUTICALS INC | APLS | 12,000 | $1.1M | 0.82% |
| 22 | SOLENO THERAPEUTICS INC | SLNO | 245,127 | $1.1M | 0.79% |
| 23 | PROTAGONIST THERAPEUTICS INC | PTGX | 38,000 | $1.0M | 0.79% |
| 24 | DOCGO INC | DCGO | 110,000 | $1.0M | 0.77% |
| 25 | IVERIC BIO INC | 46583P102 | 25,000 | $983,500 | 0.74% |
| 26 | STOKE THERAPEUTICS INC | STOK | 85,000 | $903,550 | 0.68% |
| 27 | VENTYX BIOSCIENCES INC | 92332V107 | 26,400 | $865,920 | 0.65% |
| 28 | BLUEBIRD BIO INC | 09609G100 | 249,200 | $819,868 | 0.61% |
| 29 | CYTOKINETICS INC | CYTK | 25,000 | $815,500 | 0.61% |
| 30 | PIONEER NATURAL RESOURCES CO | 723787107 | 3,800 | $787,284 | 0.59% |
| 31 | 10X GENOMICS INC | TXG | 12,000 | $670,080 | 0.50% |
| 32 | SILK ROAD MEDICAL INC | 82710M100 | 20,000 | $649,800 | 0.49% |
| 33 | TRAVERE THERAPEUTICS INC | TVTX | 40,000 | $614,400 | 0.46% |
| 34 | 2SEVENTY BIO INC | 901384107 | 59,833 | $605,510 | 0.45% |
| 35 | CHINOOK THERAPEUTICS INC | 16961L106 | 15,000 | $576,300 | 0.43% |
| 36 | KARYOPHARM THERAPEUTICS INC | KPTI | 291,332 | $521,484 | 0.39% |
| 37 | KINIKSA PHARMACEUTICALS LTD | KNSA | 30,000 | $422,400 | 0.32% |
| 38 | XENON PHARMACEUTICALS INC | XENE | 10,000 | $385,000 | 0.29% |
| 39 | ARVINAS INC | ARVN | 15,000 | $372,300 | 0.28% |
| 40 | AXOGEN INC | AXGN | 40,000 | $365,200 | 0.27% |
| 41 | HALOZYME THERAPEUTICS INC | HALO | 10,000 | $360,700 | 0.27% |
| 42 | KALVISTA PHARMACEUTICALS INC | KALV | 40,000 | $360,000 | 0.27% |
| 43 | PROGYNY INC | PGNY | 9,000 | $354,060 | 0.27% |
| 44 | AMICUS THERAPEUTICS INC | FOLD | 28,000 | $351,680 | 0.26% |
| 45 | XENCOR INC | XNCR | 12,300 | $307,131 | 0.23% |
| 46 | SAREPTA THERAPEUTICS INC | SRPT | 2,500 | $286,300 | 0.21% |
| 47 | KEROS THERAPEUTICS INC | KROS | 7,000 | $281,260 | 0.21% |
| 48 | CULLINAN ONCOLOGY INC | CGEM | 25,114 | $270,227 | 0.20% |
| 49 | INFLARX NV | IFRX | 50,000 | $223,000 | 0.17% |
| 50 | BIOCRYST PHARMACEUTICALS INC | BCRX | 20,000 | $140,800 | 0.11% |
| 51 | GOSSAMER BIO INC | GOSS | 99,088 | $118,906 | 0.09% |
| 52 | G1 THERAPEUTICS INC | 3621LQ109 | 40,000 | $99,600 | 0.07% |
| 53 | YIELD10 BIOSCIENCE INC | 98585K102 | 18,750 | $41,625 | 0.03% |
| 54 | NEKTAR THERAPEUTICS | NKTR | 28,000 | $16,106 | 0.01% |